Loading…
Research Participants Protection Modernization Act of 2011
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
57pct
10d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2011 · fourth_quarter · Health Issues
HR 2700, Global Autism Assistance Act of 2011: support for educational grant program related to autism spectrum disorders. S 1094, Combating Autism Reauthorization Act: support for autism research grant program. H. Res. 1219, HR 1217, To Repeal the Prevention and Public Health Fund: support for retention of the establishment of and appropriating funds for the Prevention and Public Health Fund in the Patient Protection and Affordable Care Act. HR 2205, Ending Defensive Medicine and Encouraging Innovative Reforms: support for prompt and fair resolution of medical disputes, enhancing quality of care, and ensuring patient access. HR 2376, Stem Cell Research Advancement Act of 2011: support for federal funding of human stem cell research. HR 2625, Research Participants Protection Modernization Act of 2011: support for protection of human subjects in research and for a reduction in regulatory burden, as appropriate.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Health Issues
HR 2700, Global Autism Assistance Act of 2011: support for educational grant program related to autism spectrum disorders. S. 1094, Combating Autism Reauthorization Act: support for autism research grant program. H.Res. 1219, HR 1217, To Repeal the Prevention and Public Health Fund: support for retention of the establishment of and appropriating funds for the Prevention and Public Health fund in the Patient Protection and Affordable Care Act. HR 2205, Ending Defensive Medicine and Encouraging Innovative Reforms: support for prompt and fair resolution of medical disputes, enhancing quality of care, and ensuring patient access. HR 2376, Stem Cell Research Advancement Act of 2011: support for federal funding of human stem cell research. HR 2625, Research Participants Protection Modernization Act of 2011: support for protection of human subjects in research and for a reduction in regulatory burden, as appropriate.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE